Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 948-957

  Marr, Nico ^a,b   Wang, Ting I ^a,b   Kam, Sarah H Y ^a,b   Hu, Yuan Shen ^a,b   Sharma, Ashish A ^a,b   Lam, Angie ^a,b   Markowski, Joy ^b   Solimano, Alfonso ^b   Lavoie, Pascal M ^a,b   Turvey, Stuart E ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 6; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR;

ADULT; ARTICLE; CELL FUNCTION; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; HUMAN CELL; INNATE IMMUNITY; MONONUCLEAR CELL; NEWBORN; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS ATTENUATION; VIRUS INDUCTION;

ADULT; AGING; CHILD; CHILD, PRESCHOOL; CYTOKINES; DEAD-BOX RNA HELICASES; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; ENDOSOMES; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, INNATE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INPATIENTS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MONOCYTES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TOLL-LIKE RECEPTORS;

EID: 84893365419     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302007     Document Type: Article

References (51)

1. Glezen, W. P., L. H. Taber, A. L. Frank, and J. A. Kasel. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140: 543-546.
2. Simoes, E. A., and X. Carbonell-Estrany. 2003. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr. Infect. Dis. J. 22: S13-S18; discussion S18-S20.
3. Nair, H., D. J. Nokes, B. D. Gessner, M. Dherani, S. A. Madhi, R. J. Singleton, K. L. O'Brien, A. Roca, P. F. Wright, N. Bruce, et al. 2010. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-Analysis. Lancet 375: 1545-1555.
4. Collins, P. L., and J. A. Melero. 2011. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 162: 80-99.
5. 2009. American Academy of Pediatrics. Respiratory syncytial virus. In Red Book: 2009 Report of the Committee on Infectious Diseases, 28th Ed. L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long, eds. American Academy of Pediatrics, Elk Grove Village, IL, p. 560-569.
6. Sharma, A. A., R. Jen, A. Butler, and P. M. Lavoie. 2012. The developing human preterm neonatal immune system: a case for more research in this area. Clin. Immunol. 145: 61-68.
7. Welliver, R. C., Sr. 2008. The immune response to respiratory syncytial virus infection: friend or foe? Clin. Rev. Allergy Immunol. 34: 163-173.
8. Loo, Y. M., J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, L. Martinez-Sobrido, S. Akira, M. A. Gill, A. García-Sastre, M. G. Katze, and M. Gale, Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335-345.
9. Yoboua, F., A. Martel, A. Duval, E. Mukawera, and N. Grandvaux. 2010. Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta. J. Virol. 84: 7267-7277.
10. Liu, P., M. Jamaluddin, K. Li, R. P. Garofalo, A. Casola, and A. R. Brasier. 2007. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 81: 1401-1411.
11. Hornung, V., J. Ellegast, S. Kim, K. Brzózka, A. Jung, H. Kato, H. Poeck, S. Akira, K. K. Conzelmann, M. Schlee, et al. 2006. 59-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
12. Schlee, M., A. Roth, V. Hornung, C. A. Hagmann, V. Wimmenauer, W. Barchet, C. Coch, M. Janke, A. Mihailovic, G. Wardle, et al. 2009. Recognition of 59 triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31: 25-34.
13. Kawai, T., and S. Akira. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143: 1-20.
14. Loo, Y. M., and M. Gale, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
15. Wang, Y., M. Swiecki, S. A. McCartney, and M. Colonna. 2011. dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity. Immunol. Rev. 243: 74-90.
16. Panne, D. 2008. The enhanceosome. Curr. Opin. Struct. Biol. 18: 236-242.
17. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14: 778-809.
18. Hovanessian, A. G. 2007. On the discovery of interferon-inducible, doublestranded RNA activated enzymes: the 29-59oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev. 18: 351-361.
19. Tayyari, F., D. Marchant, T. J. Moraes, W. Duan, P. Mastrangelo, and R. G. Hegele. 2011. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 17: 1132-1135.
20. Kwilas, A. R., M. A. Yednak, L. Zhang, R. Liesman, P. L. Collins, R. J. Pickles, and M. E. Peeples. 2010. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro. J. Virol. 84: 7770-7781.
21. Marr, N., and S. E. Turvey. 2012. Role of human TLR4 in respiratory syncytial virus-induced NF-kB activation, viral entry and replication. Innate Immun 18: 856-865.
22. Ueba, O. 1978. Respiratory syncytial virus. I. Concentration and purification of the infectious virus. Acta Med. Okayama 32: 265-272.
23. Jansen, K., D. Blimkie, J. Furlong, A. Hajjar, A. Rein-Weston, J. Crabtree, B. Reikie, C. Wilson, and T. Kollmann. 2008. Polychromatic flow cytometric high-throughput assay to analyze the innate immune response to Toll-like receptor stimulation. J. Immunol. Methods 336: 183-192.
24. Kollmann, T. R., J. Crabtree, A. Rein-Weston, D. Blimkie, F. Thommai, X. Y. Wang, P. M. Lavoie, J. Furlong, E. S. Fortuno, III, A. M. Hajjar, et al. 2009. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 183: 7150-7160.
25. Darrah, P. A., D. T. Patel, P. M. De Luca, R.W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850.
26. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
27. Hornung, V., J. Schlender, M. Guenthner-Biller, S. Rothenfusser, S. Endres, K. K. Conzelmann, and G. Hartmann. 2004. Replication-dependent potent IFNalpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J. Immunol. 173: 5935-5943.
28. Schlender, J., V. Hornung, S. Finke, M. Gunthner-Biller, S. Marozin, K. Brzózka, S. Moghim, S. Endres, G. Hartmann, and K. K. Conzelmann. 2005. Inhibition of toll-like receptor 7-And 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J. Virol. 79: 5507-5515.
29. Boyce, T. G., B. G. Mellen, E. F. Mitchel, Jr., P. F. Wright, and M. R. Griffin. 2000. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J. Pediatr. 137: 865-870.
30. Welliver, R. C. 2003. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J. Pediatr. 143(5, Suppl)S112-S117.
31. Lavoie, P. M., Q. Huang, E. Jolette, M. Whalen, A. M. Nuyt, F. Audibert, D. P. Speert, T. Lacaze-Masmonteil, H. Soudeyns, and T. R. Kollmann. 2010. Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. J. Infect. Dis. 202: 1754-1763.
32. Garcia, C. G., R. Bhore, A. Soriano-Fallas, M. Trost, R. Chason, O. Ramilo, and A. Mejias. 2010. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 126: e1453-e1460.
33. Hall, C. B., G. A. Weinberg, M. K. Iwane, A. K. Blumkin, K. M. Edwards, M. A. Staat, P. Auinger, M. R. Griffin, K. A. Poehling, D. Erdman, et al. 2009. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360: 588-598.
34. Dakhama, A., P. M. Kaan, and R. G. Hegele. 1998. Permissiveness of guinea pig alveolar macrophage subpopulations to acute respiratory syncytial virus infection in vitro. Chest 114: 1681-1688.
35. Wang, H., N. Peters, and J. Schwarze. 2006. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J. Immunol. 177: 6263-6270.
36. McDermott, D. S., K. A. Weiss, C. J. Knudson, and S. M. Varga. 2011. Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection. Future Virol 6: 963-973.
37. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira. 2005. Cell typespecific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
38. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
39. Lee, H. K., J. M. Lund, B. Ramanathan, N. Mizushima, and A. Iwasaki. 2007. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315: 1398-1401.
40. Lund, J. M., L. Alexopoulou, A. Sato, M. Karow, N. C. Adams, N. W. Gale, A. Iwasaki, and R. A. Flavell. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101: 5598-5603.
41. Krzyzaniak, M. A., M. T. Zumstein, J. A. Gerez, P. Picotti, and A. Helenius. 2013. Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog. 9: e1003309.
42. Chaiwatpongsakorn, S., R. F. Epand, P. L. Collins, R. M. Epand, and M. E. Peeples. 2011. Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer. J. Virol. 85: 3968-3977.
43. Marr, N., S. E. Turvey, and N. Grandvaux. 2013. Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective. Trends Microbiol. 21: 568-574.
44. Stone, A. E., S. Giugliano, G. Schnell, L. Cheng, K. F. Leahy, L. Golden-Mason, M. Gale, Jr., and H. R. Rosen. 2013. Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells. PLoS Pathog. 9: e1003316.
45. Saito, T., D. M. Owen, F. Jiang, J. Marcotrigiano, and M. Gale, Jr. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523-527.
46. Kim, T., S. Pazhoor, M. Bao, Z. Zhang, S. Hanabuchi, V. Facchinetti, L. Bover, J. Plumas, L. Chaperot, J. Qin, and Y. J. Liu. 2010. Aspartate-glutamate- Alaninehistidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 107: 15181-15186.
47. Jeffrey, P. K. 1998. The development of large and small airways. Am. J. Respir. Crit. Care Med. 157: S174-S180.
48. Minor, R. A., G. V. Limmon, L. Miller-DeGraff, D. Dixon, D. M. Andrews, R. J. Kaufman, and F. Imani. 2010. Double-stranded RNA-Activated protein kinase regulates early innate immune responses during respiratory syncytial virus infection. J. Interferon Cytokine Res. 30: 263-272.
49. Tabarani, C. M., C. A. Bonville, M. Suryadevara, P. Branigan, D. Wang, D. Huang, H. F. Rosenberg, and J. B. Domachowske. 2013. Novel inflammatory markers, clinical risk factors, and virus type associated with severe respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 10.1097/INF.0b013e3182a14407.
50. DeVincenzo, J. P., T. Wilkinson, A. Vaishnaw, J. Cehelsky, R. Meyers, S. Nochur, L. Harrison, P. Meeking, A. Mann, E. Moane, et al. 2010. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 182: 1305-1314.
51. Utokaparch, S., D. Marchant, J. V. Gosselink, J. E. McDonough, E. E. Thomas, J. C. Hogg, and R. G. Hegele. 2011. The relationship between respiratory viral loads and diagnosis in children presenting to a pediatric hospital emergency department. Pediatr. Infect. Dis. J. 30: e18-e23.